Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases

To date, several genetic variants that lead to a deficiency of chitotriosidase activity have been described. The duplication of 24 bp (dup24bp) in exon 10 of the CHIT1 gene, which causes a complete loss of enzymatic activity of the gene product, is the most common among the European population. The...

Full description

Bibliographic Details
Main Author: N. V. Olkhovych
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2016-02-01
Series:The Ukrainian Biochemical Journal
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2016/03/Olkhovych_1_16.pdf
_version_ 1797422273794146304
author N. V. Olkhovych
author_facet N. V. Olkhovych
author_sort N. V. Olkhovych
collection DOAJ
description To date, several genetic variants that lead to a deficiency of chitotriosidase activity have been described. The duplication of 24 bp (dup24bp) in exon 10 of the CHIT1 gene, which causes a complete loss of enzymatic activity of the gene product, is the most common among the European population. The aim of the study was to evaluate the possibility of using chitotriosidase activity as an additional biomarker in diagnosis of lysosomal storage diseases (LSDs) in Ukraine, to determine this parameter in blood plasma of the patients with various lysosomal diseases and to assess the effect of the presence of dup24bp in the CHIT1 gene on this parameter. It has been shown that chitotriosidase activity in blood plasma is a convenient additional biochemical marker in the diagnosis of some LSDs, namely Gaucher disease, Niemann-Pick disease A, B, C and GM1-gangliosidosis. Reference ranges of the normal chitotriosidase activity were determined in blood plasma of Ukrainian population and found to be 8.0-53.1 nmol 4-methylumbelliferone/h·ml of plasma. The total allele frequency of the dup24bp in the CHIT1 gene in Ukrainian population was determined, which amounted to 0.26 (323/1244) that is higher than in European population. It was indicated that molecular-genetic screening of dup24bp in the CHIT1 gene is a necessary stage in a protocol for the laboratory diagnosis of Gaucher disease, Niemann-Pick disease A, B, C as well as GM1-gangliosidosis to avoid incorrect diagnosis.
first_indexed 2024-03-09T07:29:50Z
format Article
id doaj.art-0b465a1f4e0847ca8dd40a9142eb03e1
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-09T07:29:50Z
publishDate 2016-02-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-0b465a1f4e0847ca8dd40a9142eb03e12023-12-03T06:27:16ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032016-02-01881697810.15407/ubj88.01.069Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseasesN. V. Olkhovych0State Institute of Genetic and Regenerative Medicine of NAMS of Ukraine, Kyiv; National Children’s Hospital “OHMATDYT”, Ministry of Health of Ukraine, KyivTo date, several genetic variants that lead to a deficiency of chitotriosidase activity have been described. The duplication of 24 bp (dup24bp) in exon 10 of the CHIT1 gene, which causes a complete loss of enzymatic activity of the gene product, is the most common among the European population. The aim of the study was to evaluate the possibility of using chitotriosidase activity as an additional biomarker in diagnosis of lysosomal storage diseases (LSDs) in Ukraine, to determine this parameter in blood plasma of the patients with various lysosomal diseases and to assess the effect of the presence of dup24bp in the CHIT1 gene on this parameter. It has been shown that chitotriosidase activity in blood plasma is a convenient additional biochemical marker in the diagnosis of some LSDs, namely Gaucher disease, Niemann-Pick disease A, B, C and GM1-gangliosidosis. Reference ranges of the normal chitotriosidase activity were determined in blood plasma of Ukrainian population and found to be 8.0-53.1 nmol 4-methylumbelliferone/h·ml of plasma. The total allele frequency of the dup24bp in the CHIT1 gene in Ukrainian population was determined, which amounted to 0.26 (323/1244) that is higher than in European population. It was indicated that molecular-genetic screening of dup24bp in the CHIT1 gene is a necessary stage in a protocol for the laboratory diagnosis of Gaucher disease, Niemann-Pick disease A, B, C as well as GM1-gangliosidosis to avoid incorrect diagnosis.http://ukrbiochemjournal.org/wp-content/uploads/2016/03/Olkhovych_1_16.pdf
spellingShingle N. V. Olkhovych
Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
The Ukrainian Biochemical Journal
title Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
title_full Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
title_fullStr Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
title_full_unstemmed Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
title_short Chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
title_sort chitotriosidase activity as additional biomarker in the diagnosis of lysosomal storage diseases
url http://ukrbiochemjournal.org/wp-content/uploads/2016/03/Olkhovych_1_16.pdf
work_keys_str_mv AT nvolkhovych chitotriosidaseactivityasadditionalbiomarkerinthediagnosisoflysosomalstoragediseases